PHARMACEUTICAL COMPOSITION COMPRISING SALMONELLA STRAIN AND IMMUNE CHECKPOINT INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

Title:

PHARMACEUTICAL COMPOSITION COMPRISING SALMONELLA STRAIN AND IMMUNE CHECKPOINT INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTION OR TREATMENT OF CANCER

Document Type and Number:

WIPO Patent Application WO/2023/080703

Kind Code:

A1

Abstract:

The present invention pertains to a pharmaceutical composition comprising a Salmonella strain and an immune checkpoint inhibitor as active ingredients for prevention or treatment of cancer. The present invention can be advantageously used as a prophylactic or therapeutic composition that is configured to administer a bacterium and an immune checkpoint inhibitor in combination into cancer, especially, a type of resistant cancer difficult to treat with a single anticancer therapy, to remarkably inhibit the size of a tumor, thereby improving the survival rate.

Inventors:

MIN JUNG-JOON (KR)
HONG YEONGJIN (KR)
YOU SUNG-HWAN (KR)
HUY NGUYEN DINH (KR)

Application Number:

PCT/KR2022/017209

Publication Date:

May 11, 2023

Filing Date:

November 04, 2022

Export Citation:

Click for automatic bibliography generation Help

Assignee:

UNIV NAT CHONNAM IND FOUND (KR)
CHCURE BIOTECH INC (KR)

International Classes:

A61K39/00; A61K35/74; A61K45/06; A61P35/00; C07K16/28

Domestic Patent References:

WO2020176764A1

2020-09-03

Foreign References:

KR20190082227A	2019-07-09
KR20210058825A	2021-05-24
KR20160121276A	2016-10-19
KR20140107954A	2014-09-05

Attorney, Agent or Firm:

PADO IP LAW PLLC (KR)

Download PDF:

View/Download PDF PDF Help

Previous Patent: METHOD FOR DENTAL RECORD WRITE-UP AUTOMATION AND DENTAL INSURANCE REVIEW AUTOMATION, AND SYSTEM FOR ...

Next Patent: COMPOSITION COMPRISING SKIN-SPECIFIC T CELL INHIBITOR AS ACTIVE INGREDIENT FOR PREVENTION OR TREATME...